Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease.
about
The Relevance of Sociodemographic and Health Variables on MMSE Normative Data.Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial.The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working GroupComparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.Prevalence and correlates of cognitive impairment in kidney transplant recipients.Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes.The German day-care study: multicomponent non-drug therapy for people with cognitive impairment in day-care centres supplemented with caregiver counselling (DeTaMAKS) - study protocol of a cluster-randomised controlled trial.Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic study.Balance confidence and falls in nondemented essential tremor patients: the role of cognition.The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's diseaseClinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.Validation of the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM)Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study.Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study.Longitudinal Change in Performance on the Montreal Cognitive Assessment in Older AdultsMontreal Cognitive Assessment and Modified Mini Mental State Examination in African AmericansThe Montreal Cognitive Assessment: Creating a Crosswalk with the Mini-Mental State Examination.The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons.Concordance of the Montreal cognitive assessment with standard neuropsychological measures.Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening InstrumentsRelationship between the Activities of Daily Living Questionnaire and the Montreal Cognitive Assessment.Can we improve clinical prediction of at-risk older drivers?The cognitive side of essential tremor: what are the therapeutic implications?Variability in medication taking is associated with cognitive performance in nondemented older adults.Cognitive screening in patients with diabetes in primary care.Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease: The Importance of Rehearsal.Effects of horticultural therapy on elderly' health: protocol of a randomized controlled trial.A systematic review of the diagnostic test accuracy of brief cognitive tests to detect amnestic mild cognitive impairment.Clinical Assessment of Cognitive Function in Patients with Head and Neck Cancer: Prevalence and Correlates.Multicenter Validation of an MMSE-MoCA Conversion Table.Functional Status, Cognition, and Social Relationships in Dyadic Perspective.Human predisposition to cognitive impairment and its relation with environmental exposure to potentially toxic elements.Adult Day Services Outcomes.Performance of three cognitive screening tools in a sample of older New Zealanders.Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review.Sensitivity of the Mini-Mental State Examination, Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination III to everyday activity impairments in dementia: an exploratory study.
P2860
Q30881441-3152EF89-42F8-4D18-A504-05C4E7A942B9Q33167337-C5093BD2-C11E-479D-8FE0-425FA4236C76Q33568361-7C17696F-B71A-47F2-B8C8-5837DB3425CBQ33676115-E0F21CD4-F3D3-4A00-9A3D-ABC04C776771Q33677225-44CBA76A-16D3-4589-AE2C-D57EE8019656Q33736797-F0E6892A-D1E3-4AF8-B51B-202AD5D1F802Q33909774-2B9C0E37-26E7-4E4F-B950-ED58E171FEEAQ34130449-7D733EBA-4B97-46A5-807D-37BF9963EA53Q34276157-DAF6FBCF-7E50-4B2F-9107-D8BEEB047B80Q34407321-EF0BB734-157C-43DE-BD9C-CA1786E0DC24Q34683582-33E19D7F-560A-4DDB-8357-D3403B2938B3Q34728987-D6DC5065-8515-4CE9-BC3E-BDA28FD849BDQ35022765-3FA55BC4-3820-45BD-8C8C-3E78F458A9C1Q35048396-BD8956DF-96B1-4E27-A881-5B0CF00BBB36Q36031400-5456F4A1-8E1C-4B0A-AC1D-E24EDB7A15B1Q36035069-CCA96940-E3CF-4EF0-B15B-873819335070Q36087571-C322AA8A-69B7-4413-97F4-85582001858FQ36263205-5D65E8AC-BEA8-43EA-A4DC-BAB7A14D0F69Q36278797-4568BEF2-145C-4284-9009-D663E7223B34Q36290322-56FC5B72-2EF4-4246-9CB4-DCCF57C21D35Q36438699-208FFD16-2E2C-41B8-B0E6-938A0F6379F2Q36849128-04824CC4-03D8-4BA2-8417-3A31768D6A97Q36929538-319DE635-EFEB-415D-B31D-3DE8D2DFD2E7Q37053746-3B90A930-C0FB-467B-8E65-03E0B3416D69Q37128004-37588CAE-E599-42FB-8CA8-6312FFDC4171Q37161441-14EFC2E9-A239-4961-B5E0-FD6AE8D023A2Q37300946-A9F7A485-D9A6-4131-A44E-FE2D13EB58DBQ37711854-77245EBF-560F-4E24-8402-49C97DB7C7F0Q38236661-5821FEE9-FB6B-40C7-B709-F28D5DDBDB3EQ38396390-45199D8C-CA87-4D0A-B41D-73FA2B3E2BFBQ38636030-0E01EB98-E49A-4AC0-A52C-01BFBD948B71Q38739336-4964526E-423F-4C31-B910-A8104196FFFCQ38741360-387648CC-95F5-481A-AD35-A6DB707AD05CQ38756805-5456287A-78EC-4295-9157-464BF6330865Q38859997-50FA7081-AF8A-4F8D-9928-5FEE6F643885Q38915554-D1F5FF61-6A09-480D-9B9D-BA77EDFBC353Q39018463-21F09EAB-0972-4BF6-A3D0-ACD3FBA0138BQ39053065-DC1A2FAA-2514-4160-8FDC-57525F3C5F6CQ39291241-EAAB0C3F-0CF2-45F2-AC47-E371E9E7BE19Q39423579-8887524D-945C-4262-952B-D4D60169DB5A
P2860
Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Montreal cognitive assessment: ...... airment and Alzheimer disease.
@en
Montreal cognitive assessment: ...... airment and Alzheimer disease.
@nl
type
label
Montreal cognitive assessment: ...... airment and Alzheimer disease.
@en
Montreal cognitive assessment: ...... airment and Alzheimer disease.
@nl
prefLabel
Montreal cognitive assessment: ...... airment and Alzheimer disease.
@en
Montreal cognitive assessment: ...... airment and Alzheimer disease.
@nl
P50
P1476
Montreal cognitive assessment: ...... pairment and Alzheimer disease
@en
P2093
Mário Rodrigues Simões
P356
10.1097/WAD.0B013E3182420BFE
P407
P577
2013-01-01T00:00:00Z